ASSOCIATION D'UN MODULATEUR DE POINTS DE CONTROLE IMMUNOLOGIQUES ET D'UN COMPLEXE COMPRENANT UN PEPTIDE DE PENETRATION CELLULAIRE, UN CARGO ET UN AGONISTE DES PEPTIDES TLR POUR UNE UTILISATION EN MEDECINE
The present invention provides a combination of an immune checkpoint modulator and a complex comprising a cell penetrating peptide, at least one antigen or antigenic epitope, and a TLR peptide agonist for use in medicine, in particular in the prevention and/or treatment of cancer. Moreover, the present invention also provides compositions, such as a pharmaceutical compositions and vaccines, which are useful in medicine, for example in the prevention and/or treatment of cancer.